share_log

Allarity Therapeutics | 424B5: Prospectus

Allarity Therapeutics | 424B5: Prospectus

Allarity Therapeutics | 424B5：募資說明書
美股sec公告 ·  04/09 09:19
Moomoo AI 已提取核心訊息
Allarity Therapeutics Inc. has filed a prospectus supplement on April 9, 2024, to increase the maximum aggregate offering price of its common stock from $947,000 to $1,350,000. This amendment is in accordance with the At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC. The company's public float was valued at approximately $4,052,088, with a closing stock price of $0.43 on February 9, 2024. Allarity Therapeutics has already sold $654,871 worth of common stock in the past 12 months and can sell up to an additional $695,825 under the current SEC guidelines. The company is restricted to selling no more than one-third of the aggregate market value of its common stock held by non-affiliates in any 12-month period, as long as the public float remains below $75 million.
Allarity Therapeutics Inc. has filed a prospectus supplement on April 9, 2024, to increase the maximum aggregate offering price of its common stock from $947,000 to $1,350,000. This amendment is in accordance with the At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC. The company's public float was valued at approximately $4,052,088, with a closing stock price of $0.43 on February 9, 2024. Allarity Therapeutics has already sold $654,871 worth of common stock in the past 12 months and can sell up to an additional $695,825 under the current SEC guidelines. The company is restricted to selling no more than one-third of the aggregate market value of its common stock held by non-affiliates in any 12-month period, as long as the public float remains below $75 million.
Allarity Therapeutics Inc.已於2024年4月9日提交了招股說明書補充文件，將其普通股的最高總髮行價從94.7萬美元提高至135萬美元。該修正案符合與Ascendiant Capital Markets, LLC簽訂的市場發行銷售協議。該公司的公衆持股量約爲4,052,088美元，2024年2月9日的收盤價爲0.43美元。在過去的12個月中，Allarity Therapeutics已經出售了價值654,871美元的普通股，根據美國證券交易委員會目前的指導方針，最多可以再出售695,825美元的普通股。只要公衆持股量保持在7,500萬美元以下，該公司在任何12個月內出售的普通股總市值的三分之一都不得超過其非關聯公司持有的普通股總市值的三分之一。
Allarity Therapeutics Inc.已於2024年4月9日提交了招股說明書補充文件，將其普通股的最高總髮行價從94.7萬美元提高至135萬美元。該修正案符合與Ascendiant Capital Markets, LLC簽訂的市場發行銷售協議。該公司的公衆持股量約爲4,052,088美元，2024年2月9日的收盤價爲0.43美元。在過去的12個月中，Allarity Therapeutics已經出售了價值654,871美元的普通股，根據美國證券交易委員會目前的指導方針，最多可以再出售695,825美元的普通股。只要公衆持股量保持在7,500萬美元以下，該公司在任何12個月內出售的普通股總市值的三分之一都不得超過其非關聯公司持有的普通股總市值的三分之一。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息